Are there any generic drugs of Crizotinib on the market in China?

Crizotinib is a targeted drug used to treat ALK positive non-small cell lung cancer (NSCLC). It belongs to the tyrosine kinase inhibitor class (TKI). At present, this drug has been officially launched in China and has been included in the national medical insurance directory, which has greatly improved patient accessibility. There are two main specifications in the domestic market: 250mg 60 tablets and 200mg 60 tablets. Each box usually sells for more than 10,000 yuan. However, due to the inclusion of medical insurance, the patient's out-of-pocket ratio has dropped significantly. For specific prices after reimbursement, please consult the local hospital pharmacy.

Although the original drug has been launched in China, the price still poses a burden to some patients with greater financial pressure. Therefore, many patients are also turning their attention to overseas markets. In overseas markets, the original drug of crizotinib is also expensive, with each box generally selling for more than RMB 10,000. The actual price may be higher due to factors such as exchange rate fluctuations. However, similar to the domestic situation, some countries and regions have also included it in the medical security system to reduce the financial pressure on patients.

It is worth noting that in countries such as Laos and Bangladesh, generic crizotinib drugs that are legally produced and approved by regulatory agencies are on the market. These generic drugs are basically the same as the original drugs in terms of drug ingredients and mechanism of action, and are suitable for the same indications. Among them, the generic crizotinib drug of 250mg*60 tablets produced by Lucius Pharmaceutical Factory in Laos is priced at only more than 1,000 yuan, making it an alternative option for some patients with limited financial resources.

Overall, although crizotinib is an expensive targeted therapy drug, its treatment costs have dropped significantly with the support of domestic medical insurance reimbursement policies. For patients who are temporarily unable to afford the cost of original drugs, overseas generic drugs provide them with a relatively economical medication path. Patients should take the doctor's advice into account when choosing and obtain medicines through formal channels to ensure the safety and effectiveness of treatment.

Reference materials:https://go.drugbank.com/drugs/DB08865